Literature DB >> 10541426

Age-dependent tendency to become sensitized to other classes of aeroallergens in atopic asthmatic children.

M Silvestri1, G A Rossi, S Cozzani, G Pulvirenti, L Fasce.   

Abstract

BACKGROUND: Several longitudinal studies report that allergic sensitization increases with age from childhood to adulthood.
OBJECTIVE: To evaluate whether an age-dependent tendency to become sensitized to new classes of allergens is present in atopic children, we studied retrospectively the changes in allergic sensitization in 165 asthmatic patients, monosensitized (ie, sensitized to only one class of allergens) in the first survey.
METHODS: All the children (18 months to 8 years at enrollment), attended our outpatient clinics twice, at time intervals ranging from 2 to 10 years. On each visit, sensitization to house dust mites, pollens, animal danders, and molds was determined by skin prick test.
RESULTS: We found that 43.6% (n = 72) of the patients became polysensitized on the second survey. According to age on first survey, the patients were further divided into two age groups: (1) group 1 = 18 months to < 5 years old (n = 98) and (2) group 2 = 5 to 8 years (n = 67). The transition from monosensitization to polysensitization observed in the entire population was present in both groups: 47 (47.9%) of the 98 children in group 1 and 25 (37.3%) of the 67 children in group 2 showed to be sensitized to more classes of allergens, as compared with first survey. Both in the whole population and in the two age subgroups, the changes in the frequency of monosensitization between the two evaluations were time-dependent (P < .05, each Chi(2)). Finally, to investigate whether monosensitization to a specific class of allergens could favor the development of polysensitization, we evaluated the frequency of polysensitization in the second survey in patients originally monosensitized to house dust mites or to pollens. We found that of the 130 patients originally monosensitized to house dust mites, 59 became polysensitized (45.4%), while of the 28 patients originally monosensitized to pollens, 9 became polysensitized (32.1%) (P > . 1). Similar results were obtained when patients were divided into age groups.
CONCLUSION: These data demonstrate that (1) monosensitized children are likely to become polysensitized and (2) house dust mite sensitization and, at a lower degree, pollen sensitization, apparently seem to play a "triggering" role in the development of polysensitization, since a high proportion of children originally monosensitized to house dust mites or to pollens became polysensitized.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10541426     DOI: 10.1016/S1081-1206(10)62674-9

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  19 in total

1.  Relationship between exhaled NO, respiratory symptoms, lung function, bronchial hyperresponsiveness, and blood eosinophilia in school children.

Authors:  P A Steerenberg; N A H Janssen; G de Meer; P H Fischer; S Nierkens; H van Loveren; A Opperhuizen; B Brunekreef; J G C van Amsterdam
Journal:  Thorax       Date:  2003-03       Impact factor: 9.139

Review 2.  Murine models for mucosal tolerance in allergy.

Authors:  Ursula Smole; Irma Schabussova; Winfried F Pickl; Ursula Wiedermann
Journal:  Semin Immunol       Date:  2017-08-12       Impact factor: 11.130

3.  Concomitant suppression of TH2 and TH17 cell responses in allergic asthma by targeting retinoic acid receptor-related orphan receptor γt.

Authors:  Hyeongjin Na; Hoyong Lim; Garam Choi; Byung-Keun Kim; Sae-Hoon Kim; Yoon-Seok Chang; Roza Nurieva; Chen Dong; Seon Hee Chang; Yeonseok Chung
Journal:  J Allergy Clin Immunol       Date:  2017-09-22       Impact factor: 10.793

4.  Possible reasons for lack of effect of allergen avoidance in atopy-prone infants and sensitive asthmatic patients.

Authors:  I Romei; Attilio L Boner
Journal:  Clin Rev Allergy Immunol       Date:  2005-02       Impact factor: 8.667

Review 5.  Decision-making for pediatric allergy immunotherapy for aeroallergens: a narrative review.

Authors:  Miguel Tortajada-Girbés; María Mesa Del Castillo; Helena Larramona; José Manuel Lucas; Montserrat Álvaro Lozano; Ana Isabel Tabar; Begoña Soler López; Ana Martínez-Cañavate
Journal:  Eur J Pediatr       Date:  2019-08-14       Impact factor: 3.183

6.  Bystander effect in synergy to anergy in oral tolerance of Blomia tropicalis/ovalbumin murine co-immunization model.

Authors:  C R Oliveira; E A F Taniguchi; A E Fusaro; J R Victor; C A Brito; A J S Duarte; M N Sato
Journal:  J Clin Immunol       Date:  2005-03       Impact factor: 8.317

7.  A new mechanism for inhalational priming: IL-4 bypasses innate immune signals.

Authors:  Anna M Dittrich; Hui-Chen Chen; Lan Xu; Patricia Ranney; Sean Connolly; Timur O Yarovinsky; H Kim Bottomly
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

Review 8.  Chinese Guideline on allergen immunotherapy for allergic rhinitis.

Authors:  Yixiao Bao; Jianjun Chen; Lei Cheng; Yinshi Guo; Suling Hong; Weijia Kong; He Lai; Houyong Li; Huabin Li; Jing Li; Tianying Li; Xiaoping Lin; Shixi Liu; Zheng Liu; Hongfei Lou; Juan Meng; Qianhui Qiu; Kunling Shen; Wei Tang; Zezhang Tao; Chengshuo Wang; Xiangdong Wang; Qingyu Wei; Li Xiang; Hua Xie; Yu Xu; Gehua Zhang; Yuan Zhang; Yiwu Zheng; Yuxiang Zhi; Dehua Chen; Haiyu Hong; Quansheng Li; Lin Liu; Yifan Meng; Nan Wang; Yihui Wang; Yue Zhou; Luo Zhang
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

9.  Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorised by level of benefit -the centenary of allergen specific subcutaneous immunotherapy.

Authors:  Lars Jacobsen; Ulrich Wahn; M Beatrice Bilo
Journal:  Clin Transl Allergy       Date:  2012-04-13       Impact factor: 5.871

Review 10.  Critical appraisal of Timothy grass pollen extract GRAZAX in the management of allergic rhinitis.

Authors:  Alessandra Scaparrotta; Marina Attanasi; Marianna I Petrosino; Paola Di Filippo; Sabrina Di Pillo; Francesco Chiarelli
Journal:  Drug Des Devel Ther       Date:  2015-11-03       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.